Nuvalent Inc (NUVL) Stock Analysis

Nuvalent Inc (NUVL) is a publicly traded company in the HEALTHCARE sector. It trades at $91.35, carries a market capitalization of $7.35B. This page summarizes the public market data, fundamentals, and frequently asked questions for NUVL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $91.35
• Market Cap: $7.35B
• EPS: $-6.06
• 52-Week High: $113.02
• 52-Week Low: $71.13

Market Sentiment

Nuvalent Inc currently has a Neutral sentiment score of 0.06.

About Nuvalent Inc

None

GNG Research Analysis

GNG Research scores Nuvalent Inc (NUVL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NUVL.

Frequently Asked Questions

Does NUVL pay dividends?

Nuvalent Inc (NUVL) does not currently pay a regular dividend.

What is NUVL's market cap?

Nuvalent Inc (NUVL) has a market capitalization of $7.35B with a current stock price of $91.35.